Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Microbiology and Immunology|June 21, 2007
Serotypes, antimicrobial susceptibility, and gyr A gene mutation of Campylobacter jejuni isolates from humans and chickens in ThailandSumalee Boonmar, Yukio Morita, Masahiro Fujita, et al.
The Journal of Biological Chemistry|April 15, 2011
Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxinsKengo Kitadokoro, Kousuke Nishimura, Shigeki Kamitani, et al.
Oncology Reports|June 7, 2003
Genetic detection for hematogenous micrometastasis in patients with various types of malignant tumors using Uroplakin II derived primers in polymerase chain reactionHiroyuki Hirata, Hisashi Hisatomi, Mutsushi Kawakita, et al.
Journal of Global Antimicrobial Resistance|November 23, 2016
Salmonella prevalence in meat at retail markets in Pakse, Champasak Province, Laos, and antimicrobial susceptibility of isolatesSumalee Boonmar, Yukio Morita, Chaiwat Pulsrikarn, et al.
The Journal of Veterinary Medical Science|February 6, 2009
Prevalence of hepatitis E virus (HEV) infection in wild boars (Sus scrofa leucomystax) and pigs in Gunma Prefecture, JapanChieko Sakano, Yukio Morita, Masataka Shiono, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 26, 2024
Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapyYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 3, 2025
Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary reportYusuke Kawamura, Norio Akuta, Junichi Shindoh, et al.
Internal Medicine (Tokyo, Japan)|May 6, 2026
Serum microRNA-122 Is Associated with the Therapeutic Response to Diet and Exercise Therapy in Patients with Steatotic Liver DiseaseYasuka Eriksson, Norio Akuta, Shigeki Yamamoto, et al.
International Journal of Clinical Oncology|February 12, 2025
Prospective observational study on the relationships between genetic alterations and survival in Japanese patients with metastatic castration-sensitive prostate cancer: the impact of IDC-PMasashi Kato, Hiroyuki Sato, Yushi Naito, et al.
Pageof 10